Burning Rock Biotech Limited Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Burning Rock Biotech Limited (BNR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.35 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-28.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-04-28
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|
| 2025-12-31 | 1.35M shares 20-F · filed 2026-04-28 |
| 2024-12-31 | 1.40M shares 20-F · filed 2025-04-29 |
| 2023-12-31 | 3.82M shares 20-F · filed 2024-04-29 |
| 2022-12-31 | 23.98M shares 20-F · filed 2023-04-20 |
| 2021-12-31 | 361.84K shares 20-F · filed 2023-04-20 |
| 2020-12-31 | 5.77M shares 20-F · filed 2023-04-20 |
| 2019-12-31 | 1.27M shares 20-F · filed 2022-04-29 |
| 2018-12-31 | 652.72K shares 20-F · filed 2021-03-23 |